Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ventyx Biosciences Inc shares valued at $365,461 were sold by Mohan Raju on Dec 18 ’25. At $7.72 per share, Mohan Raju sold 47,345 shares. The insider’s holdings dropped to 2,372,863 shares worth approximately $32.89 million following the completion of this transaction.
Also, Nuss John sold 12,675 shares, netting a total of over 97,840 in proceeds. Following the sale of shares at $7.72 each, the insider now holds 489,481 shares.
Before that, Nuss John had added 12,675 shares to its account. In a trade valued at $97,840, the Officer bought Ventyx Biosciences Inc shares for $7.72 each.
As published in a research note from H.C. Wainwright on November 05, 2025, Ventyx Biosciences Inc [VTYX] has been rated up from a Neutral to a Buy and the price target has been revised to $18. Analysts at Wells Fargo upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in mid March. As of March 12, 2024, Oppenheimer has increased its “Perform” rating to a “an Outperform” for VTYX. Earlier on November 07, 2023, Wells Fargo downgraded its rating. Their new recommendation was “an Equal weight” for VTYX stock which previously was a “an Overweight”.
Analyzing VTYX Stock Performance
The stock’s lowest price that day was $13.84, but it reached a high of $13.88 in the same session. During the last five days, there has been a surge of approximately 0.14%. Over the course of the year, Ventyx Biosciences Inc shares have jumped approximately 614.43%.
Support And Resistance Levels for Ventyx Biosciences Inc (VTYX)
RSI (Relative Strength Index) is 75.22 on the 14-day chart, showing overbought technical sentiment.
Is Ventyx Biosciences Inc subject to short interest?
Stocks of Ventyx Biosciences Inc saw a sharp rise in short interest on 2025-12-31 jumping by 1.87 million shares to 7.29 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 5.42 million shares. A jump of 25.64% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.46 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.46.
Which companies own the most shares of Ventyx Biosciences Inc (VTYX)?
In terms of Ventyx Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 1.01% from the previous closing price of $13.86. Analysts anticipate Ventyx Biosciences Inc stock to reach 14 by 2026, with the lowest price target being 14. In spite of this, 8 analysts ranked Ventyx Biosciences Inc stock as Buy at the end of 2026. On November 07, 2023, Stifel assigned a price target of “a Hold” to the stock and downgraded coverage with a $6.
